ImaRx inks licensing deal

Ultrasound therapy developer ImaRx Therapeutics has signed an exclusive licensing agreement with the University of Nebraska Medical Center for sonothrombolysis patents by Dr. Thomas Porter.

The licensing agreement augments ImaRx’s SonoLysis therapy of blood clots, which is in clinical trials, according to the Tucson, AZ-based vendor.

By AuntMinnie.com staff writers
November 19, 2003

Related Reading

Clinical trials begin for ImaRx, September 18, 2003

Ultrasound bubbles over into therapy, February 12, 2001

Copyright © 2003 AuntMinnie.com

Page 1 of 181
Next Page